Novartis to acquire The Medicines Company for $9.7 billion
Saturday, November 30, 2019 - 12:24
in Health & Medicine
Deal will give Novartis the experimental cholesterol-lowering RNAi therapy inclisiran
Deal will give Novartis the experimental cholesterol-lowering RNAi therapy inclisiran